These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic approach to non-functioning pituitary adenomas. Pérez-López C; Álvarez-Escolá C; Isla Guerrero A Med Clin (Barc); 2021 Mar; 156(6):284-289. PubMed ID: 33454125 [TBL] [Abstract][Full Text] [Related]
3. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors. Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804 [TBL] [Abstract][Full Text] [Related]
4. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness. Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216 [TBL] [Abstract][Full Text] [Related]
5. Contemporary issues in the evaluation and management of pituitary adenomas. Pekic S; Stojanovic M; Popovic V Minerva Endocrinol; 2015 Dec; 40(4):307-19. PubMed ID: 25900682 [TBL] [Abstract][Full Text] [Related]
7. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution. D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551 [TBL] [Abstract][Full Text] [Related]
10. Clinical review 65. Evaluation and treatment of the patient with a pituitary incidentaloma. Molitch ME J Clin Endocrinol Metab; 1995 Jan; 80(1):3-6. PubMed ID: 7829630 [TBL] [Abstract][Full Text] [Related]
11. Pediatric pituitary adenoma: a series of 42 patients. Pandey P; Ojha BK; Mahapatra AK J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410 [TBL] [Abstract][Full Text] [Related]
12. Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas. Das L; Gupta N; Dutta P; Walia R; Vaiphei K; Rai A; Radotra BD; Gupta K; Sreedharanunni S; Ahuja CK; Bhansali A; Tripathi M; Sood R; Dhandapani S Front Endocrinol (Lausanne); 2021; 12():774686. PubMed ID: 34975752 [TBL] [Abstract][Full Text] [Related]